A Gene May Influence How Much Cats Purr and Meow

SUNDAY, June 8, 2025 (HealthDay News) — Why does your cat purr when you pet it — or meow when dinner’s late?

A new study from the Wildlife Research Center at Kyoto University in Japan suggests the answer could be in its genes.

Researchers looked at the androgen receptor gene in 280 spayed or neutered mixed-breed cat...

An Expert's Guide to Keeping Middle-Age Spread at Bay

SATURDAY, June 7, 2025 (HealthDay News) — You're not just getting older, you're probably getting bigger.

Between their 20s and 40s, most Americans can expect to put on 10 to 25 pounds — and after 30, exercise may not have the same payoff it once did. 

It's not just you, but Mother Nature at work. 

"Your me...

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 (HealthDay News) — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.

If approved, the shot — lenacapavir — would be given twice a year and could be a big step forward in the fight against HIV.

Drugmaker Gilead Sciences test...

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

FRIDAY, June 6, 2025 (HealthDay News) — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions.

The request came Thursday from top officials in California, Massachusetts, New Jersey and New York.

They said in a petition ...

ESPN's Jay Harris Diagnosed With Prostate Cancer

FRIDAY, June 6, 2025 (HealthDay News) — Longtime ESPN “SportsCenter” anchor Jay Harris has been diagnosed with prostate cancer and is scheduled to have surgery on June 10.

Harris, 60, wrote about his experience in an essay posted June 5 on ESPN’s Front Row website. He said he got the news “over a month ago,&rd...

Immunotherapy Effective Against Stomach Cancer

FRIDAY, June 6, 2025 (HealthDay News) — Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical trial says.

People treated with durvalumab and chemotherapy were much more likely to go into remission, according to clinical trial results published June 1 in  Th...